Benoît Pastour
Corporate Officer/Principal chez ALTUR INVESTISSEMENT
Provenance du réseau au premier degré de Benoît Pastour
Entité | Type d'entité | Industrie | |
---|---|---|---|
Turenne Capital Partenaires SA
Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France.
48
| Subsidiary | Investment Managers | 48 |
Nord Capital Partenaires SAS
12
| Joint Venture | Investment Managers | 12 |
Private Eq Fd/Alt Invt | Investment Managers | 11 | |
Aterovax SA
Aterovax SA Medical/Nursing ServicesHealth Services Aterovax SA develops in vitro diagnostic products for the management and assessment of cardiovascular diseases. Its products include diagnostic blood tests for determining and measuring activity of the cardiovascular biomarkers secretory phospholipase A2 (sPLA2) and secretory phospholipase A2-IIA (sPLA2-IIA) which provide physicians clinical information about the presence of a destabilized atherosclerotic plaque. The company was founded by Alain Tedgui, Ziad Mallat, Philippe Gabriel Steg, Joelle Benessiano and Jean-Marie Freyssinet on June 29, 2006 and is headquartered in Paris, France.
5
| Holding Company | Medical/Nursing Services | 5 |
Vauban Partenaires SA
Vauban Partenaires SA Investment ManagersFinance Vauban Partenaires SA (VP) is an independent boutique-sized private equity firm established in 1992 and based in Paris. Crédit Agricole SA (XP: ACA) is a significant minority shareholder. The firm operates in close relationship with their majority-owned subsidiary Participex Gestion, based in Lille in northern France. Both firms manage private equity funds including regional development funds. Their clients are leading financial institutions, regional banks and insurance companies. Their lead investors are regional subsidiaries of Crédit Agricole.
2
| Private Company | Investment Managers | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Benoît Pastour via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ALTRAN TECHNOLOGIES | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member | |
VALEO | Auto Parts: OEM | Chief Tech/Sci/R&D Officer | |
Sofimac Innovation SAS
Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Investment Managers | Private Equity Investor Private Equity Investor | |
Ventech SA
Ventech SA Investment ManagersFinance Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US. | Investment Managers | Private Equity Investor | |
Le Furet du Nord SA
Le Furet du Nord SA Specialty StoresRetail Trade Le Furet du Nord SA retails reading materials and multimedia products. The firm offers books, software, and video games. It provides delivery service. The company was founded in 1959 and is headquartered in Lomme, France. | Specialty Stores | Chairman Chairman | |
Kaneka Eurogentec SA
Kaneka Eurogentec SA BiotechnologyHealth Technology Kaneka Eurogentec SA distributes reagents, kits and other related products for the biotechnology, pharmaceutical, and diagnostic sectors. It offers a range of services, from basic research in genomics and proteomics, to services associated with the development and manufacture of diagnostic and therapeutic products. The company was founded in 1985 and is headquartered in Seraing, Belgium. | Biotechnology | Director/Board Member | |
Naxicap Partners SA
Naxicap Partners SA Investment ManagersFinance Naxicap Partners SA operates as a private equity firm. It invests in hospitals, pharmaceuticals, business services, information technology, textile, and consumer goods sectors. The company was founded in 1995 and is headquartered in Paris, France. | Investment Managers | Chief Investment Officer Private Equity Analyst | |
Paluel-Marmont Capital SA
Paluel-Marmont Capital SA Investment ManagersFinance Paluel-Marmont Capital SA (PMC) is the wholly-owned private equity subsidiary of Compagnie Lebon (XP: LBON) in France. Formerly known as Lebon Développement, the firm was established in 1991. Located in Paris, PMC invests their own equity in leveraged buy-outs in small- and mid-size businesses, sharing their professional expertise and business network with investee company management. | Investment Managers | Director/Board Member | |
Participex Gestion SAS
Participex Gestion SAS Investment ManagersFinance Participex Gestion SAS is a Private Equity firm, a subsidiary of Vauban Partenaires SA founded in 1974. Participex Gestion SAS is headquartered in Lille, France. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Investor | |
XAnge Private Equity SA
XAnge Private Equity SA Investment ManagersFinance XAnge Private Equity SA (XAnge Private Equity) is a private equity portfolio management firm which was created in 2003 by La Poste and ABN AMRO and is headquartered in France. | Investment Managers | Private Equity Investor | |
National Aeronautics & Space Administration | General Government | Corporate Officer/Principal | |
THERADIAG | Medical Specialties | Corporate Officer/Principal | |
Université de Bordeaux | College/University | Graduate Degree | |
Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Masters Business Admin | |
Laboratoire Cerba SA
Laboratoire Cerba SA Miscellaneous Commercial ServicesCommercial Services Laboratoire Cerba SA provides medical research services. It conducts tests in the fields of virology, autoimmune disease, allergy, endocrinology, oncology, toxicology and molecular genomics. The company was founded in 1967 and is headquartered in Saint-Ouen-l'Aumône, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member | |
Université Paris Dauphine-PSL | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
École Centrale Paris | College/University | Undergraduate Degree | |
ESSEC Business School | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
Institut d'Optique Graduate School | College/University | Undergraduate Degree | |
A Plus Finance SA
A Plus Finance SA Investment ManagersFinance A Plus Finance SA (A Plus Finance) is a private equity firm. The firm is founded in 1998 by Niels Court Payen andFrédéric Bayol. The firm headquartered in Paris, France. | Investment Managers | Private Equity Analyst | |
Siparex XAnge Venture SAS
Siparex XAnge Venture SAS Investment ManagersFinance Siparex XAnge Venture SAS is an Independent Venture Capital firm founded in 1977 by Benjamin Teszner. Siparex XAnge Venture SAS is headquartered in Paris. | Investment Managers | Director/Board Member Private Equity Analyst | |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
Arterial Remodelling Technologies SA
Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Chairman | |
NANOBIOTIX | Medical Specialties | Director/Board Member | |
NOVACYT | Medical Specialties | Founder | |
Covagen AG
Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member | |
Renaissance Corporate SAS | Investment Managers | Chief Executive Officer President President | |
Gene Signal SAS
Gene Signal SAS Pharmaceuticals: GenericHealth Technology Gene Signal is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company's innovative therapies use precisely targeted angiogenic (inducing vascular growth) or angiostatic (inhibiting vascular growth) agents, derived from genes that are exclusively involved with the angiogenesis process . The firm's therapies aim to provide a more targeted alternative to existing solutions like Vascular Endothelial Growth Factors which impact other physiological phenomena in addition to angiogenesis. Gene Signal's targeted therapies represents a novel, next-generation approach to the management of angiogenesis based conditions and offer the potential to improve treatment options for concerned patients. Founded in 2000, Gene Signal has assembled an strong leadership team that includes scientific, medical, regulatory, and business professionals with successful track records in developing and bringing to market state of the art drugs. Gene Signal continues to develop its angiogenesis modulating technology and has built a significant intellectual property portfolio, as well as a robust clinical and preclinical pipeline. | Pharmaceuticals: Generic | Chief Executive Officer | |
Gene Signal International SA
Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Société Petroliere du Bec d'Ambes
Société Petroliere du Bec d'Ambes Miscellaneous Commercial ServicesCommercial Services Société Petroliere du Bec d'Ambes provides refrigerated storage facility services. The company is headquartered in Carbon-Blanc, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
Astra Zeneca Holding France SAS
Astra Zeneca Holding France SAS Pharmaceuticals: MajorHealth Technology Astra Zeneca Holding France SAS operates as a holding firm with interest in pharmaceuticals. The company was founded in 1994 and is headquartered in Rueil-Malmaison, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BASF France SAS
BASF France SAS Chemicals: Major DiversifiedProcess Industries BASF France manufactures and markets coating products. The company is headquartered in Levallois-Perret, France. | Chemicals: Major Diversified | Corporate Officer/Principal | |
Medtronic France SAS
Medtronic France SAS Medical/Nursing ServicesHealth Services Medtronic France SAS provides medical equipment and medical technology services. The company was founded by Earl Bakken and Palmer Hermundslie in 1949 and is headquartered in Boulogne-Billancourt, France. | Medical/Nursing Services | Corporate Officer/Principal | |
Stimulus SAS
Stimulus SAS Miscellaneous Commercial ServicesCommercial Services Stimulus SAS is a holding company, which provides consulting services for management and health at work. It offers anti-stress tools to companies. The company was founded by Patrick Légeron in 1989 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Extens SAS
Extens SAS Investment ManagersFinance Extens SAS (Extens) is an independent venture capital firm headquartered in Paris, France. The firm was founded by Arnaud Houette and Quentin Jacomet in 2013. | Investment Managers | Founder Private Equity Investor | |
L3S Partnership | Corporate Officer/Principal | ||
Essling Capital SAS
Essling Capital SAS Investment ManagersFinance Essling Capital SAS (Essling Capital) is an independent private equity firm founded in 2016 by Frank-Noël Vandenberghe. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
Geneo Capital Entrepreneur SA
Geneo Capital Entrepreneur SA Investment ManagersFinance Geneo Capital Entrepreneur SA is an Independent Private Equity/Venture Capital firm founded in 2018 by Fanny Letier. Geneo Capital Entrepreneur SA is headquartered in Neuilly-sur-Seine. | Investment Managers | Private Equity Investor | |
BrainTale SAS
BrainTale SAS Packaged SoftwareTechnology Services BrainTale SAS engages in the development and distribution of diagnosis and prognosis tools for brain injured patients. Its products include BrainQuant and BrainScore-coma. The company was founded by Vincent Perlbarg, Julie Rachline, Didier Cassereau, Louis Puybasset, Damien Galanaud, and Lionel Velly on July 6, 2018 and is headquartered in Paris, France. | Packaged Software | Chief Executive Officer |
Statistiques
Internationale
France | 43 |
Etats-Unis | 4 |
Suisse | 3 |
Belgique | 2 |
Espagne | 2 |
Sectorielle
Health Technology | 17 |
Finance | 14 |
Consumer Services | 9 |
Commercial Services | 7 |
Producer Manufacturing | 2 |
Opérationnelle
Director/Board Member | 85 |
Private Equity Investor | 70 |
Chairman | 36 |
Corporate Officer/Principal | 36 |
Private Equity Analyst | 29 |
Relations les plus connectées
Insiders | |
---|---|
Mounia Chaoui-Roulleau | 27 |
François Lombard | 19 |
Michel Andre Henri Cognet | 14 |
Christian Maugey | 14 |
Christian Toulouse | 14 |
Olivier Motte | 14 |
Julie Rachline | 13 |
Quentin Jacomet | 12 |
Eric Viaud | 9 |
François Picarle | 8 |
Hubert Michalowski | 8 |
Marie Desportes | 6 |
Antoine Ferry | 5 |
Marine Bussienne | 4 |
Bervin Bouani | 4 |
- Bourse
- Insiders
- Benoît Pastour
- Connexions Sociétés